Will Garneau

102 posts

Will Garneau banner
Will Garneau

Will Garneau

@willgarneau

Assistant Professor of Medicine at Johns Hopkins. I’m a clinician and researcher whose interests include emerging diseases, health technology and standup comedy

Baltimore, MD 参加日 Ağustos 2015
351 フォロー中234 フォロワー
Will Garneau がリツイート
JAMA Network Open
JAMA Network Open@JAMANetworkOpen·
For hospitalized patients with opioid use disorder, risk of patient-directed discharge (PDD) was reduced by 29% with each additional 10mg of methadone given within the first 24 hours of care. ja.ma/4rYPtVK
JAMA Network Open tweet media
English
0
3
4
1.8K
Will Garneau
Will Garneau@willgarneau·
We recently shared our findings describing differences in clinical evaluation for mpox during the 2022 epidemic. Our study examined adherence to CDC guidelines for the care of persons with suspected mpox.
English
1
0
5
383
Will Garneau がリツイート
Johns Hopkins GIM
Johns Hopkins GIM@Hopkins_GIM·
WINNER! Milton W. Hamolsky Awards are presented to junior faculty whose abstracts are "the most outstanding among those submitted to the national meeting." Congrats, Dr. Gupta.🏆 #SGIM24 #HopkinsGIM
Johns Hopkins GIM tweet media
Johns Hopkins GIM@Hopkins_GIM

Dr. @rgupta729's, a finalist for the Milton W. Hamolsky Awards at #SGIM24, presents an analysis helping us understand the impact of insurance companies' prior authorization policies on outpatient providers. #HopkinsGIM

English
0
1
5
2.3K
Will Garneau がリツイート
Nicky Mehtani
Nicky Mehtani@NickyMehtani·
When my Medicaid patients learn that I study the role of psychedelic therapies in SUD Tx, they often ask when they'll be available. The answer: it depends. Grateful to share this @JAMANeuro perspective on aligning psychedelics research with health equity. jamanetwork.com/journals/jaman…
English
1
6
26
4.1K
Will Garneau
Will Garneau@willgarneau·
Thank you to the research team at Johns Hopkins. I look forward to more research to inform practice in order to best serve patients
English
1
0
0
195
Will Garneau
Will Garneau@willgarneau·
Yesterday we published a study of outcomes for patients with mpox infections during the 2022 outbreak. Immunosuppression was a strong risk factor for hospitalization.
English
1
0
8
2.3K